| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |